MGMT and glioblastoma: For example, MGMT (O6-methylguanine–DNA methyltransferase) promoter methylation [7], transcriptomic [38], DCE-MRI [16], blood derive biomarkers [39] or diffusion MRI [40] have already been studied for their potential in the survival prediction of GBM patients.